MORGAN STANLEY - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$18,422,353
-25.2%
366,833
-5.8%
0.00%0.0%
Q2 2023$24,616,149
+2.8%
389,496
-26.8%
0.00%
-33.3%
Q1 2023$23,949,392
+17.4%
532,327
+14.3%
0.00%
+50.0%
Q4 2022$20,394,826
-79.9%
465,529
-69.8%
0.00%
-85.7%
Q3 2022$101,451,000
+20.9%
1,539,708
-7.3%
0.01%
+27.3%
Q2 2022$83,887,000
+485.0%
1,660,792
+639.9%
0.01%
+450.0%
Q1 2022$14,339,000
-3.8%
224,475
+61.3%
0.00%0.0%
Q4 2021$14,909,000
+7.5%
139,177
+3.2%
0.00%0.0%
Q3 2021$13,866,000
-70.6%
134,883
-74.8%
0.00%
-66.7%
Q2 2021$47,098,000
+681.3%
535,446
+763.6%
0.01%
+500.0%
Q1 2021$6,028,000
-77.1%
62,001
-73.5%
0.00%
-75.0%
Q4 2020$26,269,000
+321.2%
234,241
+248.2%
0.00%
+300.0%
Q3 2020$6,236,000
+5.1%
67,278
-11.5%
0.00%0.0%
Q2 2020$5,931,000
+33.9%
76,040
+0.4%
0.00%0.0%
Q1 2020$4,430,000
-51.3%
75,751
-33.2%
0.00%
-50.0%
Q4 2019$9,092,000
+165.9%
113,484
+143.8%
0.00%
+100.0%
Q3 2019$3,419,000
-35.3%
46,542
-17.0%
0.00%0.0%
Q2 2019$5,287,000
+75.1%
56,048
+48.6%
0.00%0.0%
Q1 2019$3,020,000
-76.7%
37,726
-84.3%
0.00%
-75.0%
Q4 2018$12,981,000
+42.8%
240,813
+106.7%
0.00%
+100.0%
Q3 2018$9,093,000
-61.6%
116,482
-68.8%
0.00%
-66.7%
Q2 2018$23,705,000
+38.0%
373,422
+99.4%
0.01%
+20.0%
Q1 2018$17,175,000
-33.8%
187,297
-45.5%
0.01%
-28.6%
Q4 2017$25,937,000
+520.7%
343,955
+473.4%
0.01%
+600.0%
Q3 2017$4,179,000
+71.9%
59,983
+25.0%
0.00%0.0%
Q2 2017$2,431,000
-69.5%
47,980
-75.9%
0.00%0.0%
Q1 2017$7,972,000
+50.4%
199,336
+5.5%
0.00%0.0%
Q4 2016$5,302,000
+1800.4%
188,986
+1916.7%
0.00%
Q3 2016$279,000
-56.1%
9,371
-70.1%
0.00%
Q2 2016$635,000
+21.9%
31,366
+8.6%
0.00%
Q1 2016$521,000
-35.6%
28,888
-5.9%
0.00%
Q4 2015$809,000
+37.8%
30,697
+11.6%
0.00%
Q3 2015$587,000
+1444.7%
27,508
+1830.4%
0.00%
Q2 2015$38,0001,4250.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 380,012$42,618,0008.86%
DAFNA Capital Management LLC 206,911$23,205,0006.90%
Casdin Capital, LLC 1,550,000$173,833,0005.15%
Eagle Health Investments LP 62,060$6,960,0004.45%
SIB LLC 54,912$6,158,0004.11%
CADIAN CAPITAL MANAGEMENT, LP 1,059,450$118,817,0003.05%
Tri Locum Partners LP 73,906$8,289,0003.01%
Integral Health Asset Management, LLC 85,000$9,533,0002.84%
MAKENA CAPITAL MANAGEMENT LLC 38,924$4,365,0002.42%
Rock Springs Capital Management LP 842,000$94,430,0002.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders